Clifton, Rebecca Gersnoviez
- George Washington University (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #474
- Sustained Excellence
- Top 5% Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2013 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$6.7M
Full award amounts, FY2023
Award Records
5
Records listing this PI
Award-Linked Rank
#474
By linked amount among FY2023 PIs
Earliest Year Loaded
2013
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Clifton, Rebecca Gersnoviez as a PI. Multi-PI records show the full award amount for context.
- 2U24HD036801-26U24Contact PINICHD Maternal-Fetal Medicine Units (MFMU) Network: Data CoordinatingCenter$5.7Maward amount
- 3U24HD036801-26S3U24Contact PIPreeclampsia Biomarker Project (FNIH- Administrative Supplement)$421.8Kaward amount
- $333.2Kaward amount
- $250Kaward amount
- 5U24HL140168-06U24Contact PI2/2: A Randomized Controlled Trial of Pravastatin for the Prevention of Preeclampsia in High Risk Women$1award amount
Award organization
Organizations that administered FY2023 awards listing Clifton, Rebecca Gersnoviez as a PI.
FY2023 award administered by George Washington University (DC).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2013First NIH AwardGeorge Washington University
- 2014$500K Cumulative Funding
- 2014$1M Cumulative Funding
- 2014Entered Top 50% NationallyRanked #8360
- 2015$2M Cumulative Funding
- 2019$5M Cumulative Funding
- 2019$10M Cumulative Funding
- 2019Entered Top 25% NationallyRanked #38
- 2019Entered Top 10% NationallyRanked #38
- 2019Entered Top 5% NationallyRanked #38
- 2019Entered Top 1% NationallyRanked #38
- 2020$25M Cumulative Funding
- 2021$50M Cumulative Funding